Société Crinetics Pharmaceuticals, Inc.
Actions
CRNX
US22663K1079
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
44 USD | +4,46% | +1,29% | +23,66% |
Métier
Nombre d'employés: 290
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100,0
%
| 5 | 100,0 % | 4 | 100,0 % | -15,28% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States and Australia
100,0
%
| 5 | 100,0 % | 4 | 100,0 % | -15,28% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Stephen Betz
FOU | Founder | 58 | 01/01/08 |
Scott Struthers
FOU | Founder | 62 | 01/01/08 |
Marc Wilson
DFI | Director of Finance/CFO | 45 | 01/01/18 |
Dana Pizzuti
CTO | Chief Tech/Sci/R&D Officer | 69 | 30/09/22 |
Matt McDowell
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jeff Knight
COO | Chief Operating Officer | 53 | 30/08/21 |
Chris Robillard
PRN | Corporate Officer/Principal | - | 21/03/22 |
Garlan Adams
LAW | General Counsel | - | 16/06/21 |
Michael Monahan
LAW | General Counsel | - | 01/06/18 |
Brian Russell
PRN | Corporate Officer/Principal | - | 01/03/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Wendell Wierenga
CHM | Chairman | 76 | 01/10/15 |
Matthew Fust
BRD | Director/Board Member | 59 | 01/02/18 |
Director/Board Member | 71 | 03/09/20 | |
Caren Deardorf
BRD | Director/Board Member | 59 | 11/03/22 |
Director/Board Member | 60 | 03/01/22 | |
Weston Nichols
BRD | Director/Board Member | 39 | 01/02/18 |
Scott Struthers
FOU | Founder | 62 | 01/01/08 |
Stephanie Okey
BRD | Director/Board Member | 64 | 15/07/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 78 744 364 | 74 939 799 ( 95,17 %) | 0 | 95,17 % |
Coordonnées société
Crinetics Pharmaceuticals, Inc.
6055 Lusk Boulevard
92121, San Diego
+858 450 6464
http://www.crinetics.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+23,66% | 3,32 Md | |
+1,77% | 42,75 Md | |
+47,70% | 41,61 Md | |
+12,24% | 41,34 Md | |
-8,83% | 26,59 Md | |
+7,44% | 25,49 Md | |
-23,01% | 18,12 Md | |
+30,56% | 12,24 Md | |
-1,82% | 11,76 Md | |
+8,35% | 11 Md |
- Bourse
- Actions
- Action CRNX
- Société Crinetics Pharmaceuticals, Inc.